ANÁLISIS DE SUPERVIVENCIA TRAS NEOADYUVANCIA EN CÁNCER DE PÁNCREAS RESECABLE CON FACTORES DE RIESGO

Dades bàsiques

Protocol:: ICI20-00047
EURDRACT:: 2021-000317-17
NCT:
Centre:: HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Any inici:: 2022
Any de finalització:: 2026

ENSAYO CLÍNICO

Objectius del projecte

Objetivo Principal: Evaluar la supervivencia global en pacientes tratados con quimioterapia neoadyuvante antes de la resección quirúrgica y compararla frente a la supervivencia en pacientes tratados solo con tratamiento adyuvante tras la resección quirúrgica. Objetivos Secundarios: Evaluar en ambas ramas (experimentar vs control): - supervivencia libre de enfermedad - ciclos completados. - recaídas locales y metastásicas - morbimortalidad post-quirúrgica - tasas de resección R0 - seguridad del tratamiento neoadyuvante

Documents

No hi ha documents

Participants

Roberto Pedro Díaz Beveridge

Investigador Colaborador
Eva María Montalvá Orón

Investigador Colaborador
Irene Torres Espallardo

Investigador Colaborador
Rafael López Andújar

Investigador Colaborador
Jorge Aparicio Urtasun

Investigador Colaborador
Judith Pérez Rojas

Investigador Colaborador
Lidia Argüello Viudez

Investigador Colaborador
Paula Richart Aznar

Investigador Colaborador
Asunción Torregrosa Andrés

Investigador Colaborador
Adolfo Del Val Antoñana

Investigador Colaborador
Francisco Orbis Castellanos

Investigador Colaborador
José Luis Poveda Andrés

Investigador Colaborador
Javier Maupoey Ibáñez

Investigador Colaborador
María Dolores Higon Ballester

Investigador Colaborador
Cristina Ballester Ibáñez

Investigador Principal
Andrea Boscà Robledo

Investigador Colaborador
Raquel Sánchez Vañó

Investigador Colaborador
David Calatayud Mizrahi

Investigador Colaborador
Antonio Conde Moreno

Investigador Colaborador
Ana Hernando Sanz

Investigador Colaborador
Sonia Gines Cardenas

Investigador Colaborador
Inmaculada Ortiz Polo

Investigador Colaborador
Africa Almendros Riaza

Investigador Colaborador
Fatima Tomas Medina

Investigador Colaborador
Oussama Bardouz Gouguasse

Investigador Colaborador
Silvia Maestro Huguet

Investigador Colaborador
Maria Del Mar San Juan Tubilleja

Investigador Colaborador
Elena Teijeiro Vazquez

Investigador Colaborador

Veure tots els Investigadors

Grups d'Investigació

Investigación Clínica y Traslacional en Cáncer

Leader

José Gómez Codina
Hepatología, Cirugia Hepatobiliopancreática y Trasplantes

Leader

Marina Berenguer Haym
Farmacogenética

Investigador Principal

María José Herrero Cervera
Investigacion Biomédica en Imagen (GIBI 2-30)

Investigador Principal

Leonor Cerdá Alberich
Núcleo de investigación traslacional integrado Urológico de Valencia (NITIUV)

Leader

César David Vera Donoso
Endoscopia Digestiva y Hepática

Leader

Vicente Pons Beltrán
Unidad de Descubrimiento de Fármacos (UDF)

Investigador Principal

Leonor Puchades Carrasco
Grupo de Investigación de Farmacia

Investigador Principal

Javier García Pellicer

Finançadors - Promotors

FUNDACION GESTION INVESTIGACION BIOMEDICA CADIZ

Resultats de l'Assaig Clínic

Publicacions en Revistes 199

[[Tranaslated article]]Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.

López DF; (...); Ortiz-Romero, P. L.

Article. 10.1016/j.ad.2022.11.013. 2023

[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025

[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.

Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.09.006. 2024

A Gadolinium(III) Complex Based on Pyridoxine Molecule with Single-Ion Magnet and Magnetic Resonance Imaging Properties.

Orts-Arroyo, Marta; (...); Martinez-Lillo, Jose

Article. 10.3390/ijms25042112. 2024

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer.

Okuno, Keisuke; (...); Goel, Ajay

Letter. 10.1186/s12943-022-01699-2. 2023

A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro

Article. 10.33393/grhta.2022.2333. 2022

A Phase II Trial of Stereotactic Body Radiation Therapy and Androgen Deprivation for Oligometastases in Prostate Cancer (SBRT-SG 05).

Conde-Moreno, Antonio J; (...); Ferrer, Carlos

Article. 10.1016/j.prro.2024.04.022. 2024

A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24.

González-San Segundo C; (...); Couñago F

Article. 10.1111/bju.16484. 2024

A Smart Digital Health Platform to Enable Monitoring of Quality of Life and Frailty in Older Patients with Cancer: A Mixed-Methods, Feasibility Study Protocol.

Papachristou, Nikolaos; (...); Bamidis, Panagiotis D.

Article. 10.1016/j.soncn.2023.151437. 2023

An exosome-based liquid biopsy predicts depth of response and survival outcomes to cetuximab and panitumumab in metastatic colorectal cancer: The EXONERATE Study.

Xu, Caiming; (...); Goel, Ajay

Article. 10.1158/1078-0432.CCR-24-1934. 2025

CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study

Frezza, Anna Maria; (...); Gronchi, Alessandro

Article. 10.1002/cam4.5015. 2022

Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing.

Ortiz A; (...); Rodriguez M

Article. 10.1159/000528784. 2023

Cluster-Partial Least Squares (c-PLS) regression analysis: Application to miRNA and metabolomic data.

Kuligowski, Julia; (...); Quintas, Guillermo

Article. 10.1016/j.aca.2023.342052. 2024

CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)

Aguilera, V.; (...); Berenguer, M.

Meeting Abstract. 2023

CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study

Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria

Meeting Abstract. 2023

ComBat harmonization in different PET imaging scenarios

Gandia-Ferrero, M.; (...); Marti-Bonmati, L.

Meeting Abstract. 2023

Comparing the direct assessment of steatosis in liver explants with mid- and near-infrared vibrational spectroscopy, prior to organ transplantation.

Rienda, Ivan; (...); Quintas, Guillermo

Article. 10.1039/d3an01184d. 2023

Comparison of protocols with respiratory-gated (4D) motion compensation in PET/CT: open-source package for quantification of phantom image quality.

Martinez-Movilla, Andrea; (...); Carles, Montserrat

Article. 10.1186/s40658-022-00509-4. 2022

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023

Characteristics and outcomes of advanced melanoma patients with complete response and elective discontinuation of first-line anti-programmed death-1 monotherapy: A real-world multicentre observational cohort study.

Ochenduszko, Sebastian; (...); Maiques, Inmaculada Maestu

Article. 10.1111/pcmr.13093. 2023

Chronic inguinal pain post-hernioplasty. Laparo-endoscopic surgery vs lichtenstein repair: systematic review and meta-analysis.

Lillo-Albert G; (...); Pous-Serrano S

Article. 10.1007/s10029-024-03077-x. 2024

Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024

Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024

Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1111/liv.15766. 2024

Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning.

Munoz, Andres J.; (...); Hernandez-Presa, Miguel Angel

Article. 10.1016/j.thromres.2023.06.015. 2023

Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.

Lopez-Pascual, Ernesto; (...); Castell, Jose V.

Article. 10.3390/ijms25105203. 2024

Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

Contreras-Toledo, Debora; (...); Carmona-Bayonas, Alberto

Article. 10.1038/s41416-023-02563-w. 2024

Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, real-world evidence in Spain (GEM 2002-BECARE)

Soria, A.; (...); Cerezuela-Fuentes, P.

Meeting Abstract. 10.1016/j.annonc.2023.09.2248. 2023

Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study).

Marquez-Rodas, Ivan; (...); Berrocal, Alfonso

Article. 10.1093/neuonc/noae116. 2024

Endoscopic findings of paraduodenal or groove pancreatitis.

Lopez-Munoz, Pedro; (...); Pons-Beltran, Vicente

Article. 10.1055/a-1773-0499. 2022

Enhancing the accuracy of mid-infrared spectroscopy-based liver steatosis quantification using digital image analysis as a reference.

Rienda, Ivan; (...); Quintas, Guillermo

Article. 10.1039/d3an00324h. 2023

European Association of Urology (EAU) Testicular Cancer Guidelines Panel: A new prognostic factor risk group classification for patients with clinical stage 1 seminoma in active surveillance.

Boormans, Joost; (...); Laguna, Pilar

Meeting Abstract. 2023

Evaluation of EMBARK criteria patients. Real-world data on prostate cancer biochemical recurrence

Centelles Hidalgo, Elena; (...); Lopez-Campos, Fernando

Meeting Abstract. 2024

Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study.

Valladares-Ayerbes M; (...); Lloansí Vila A

Article. 10.3390/cancers14246075. 2022

Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer

Vera, Ruth; (...); Madrigal-Rubiales, Beatriz

Article. 10.1007/s12094-022-02873-0. 2022

Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.

Vera, Ruth; (...); Madrigal-Rubiales, Beatriz

Article. 10.1016/j.patol.2022.06.004. 2023

Extra-Skeletal Osteosarcoma of the Prostate After Treated Prostatic Acinar Adenocarcinoma: A Case Report and Review of the Literature.

García CR; (...); Segura FG

Article. 10.1177/10668969241283735. 2024

Feasibility and Short-Term Outcomes in Liver-First Approach: A Spanish Snapshot Study (the RENACI Project).

Serradilla-Martín M; (...); Ramia JM

Article. 10.3390/cancers16091676. 2024

Fibrillary glomerulonephritis: more frequent than it seems? The diagnostical importance of immunohistochemistry.

Viejo-Boyano I; (...); Hernández-Jaras J

Letter. 10.1016/j.nefroe.2023.05.022. 2024

FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, Laura; (...); Berenguer, Marina

Meeting Abstract. 2024

FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis

Martinez-Arenas, L.; (...); Berenguer, M.

Meeting Abstract. 2024

FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.

Martinez-Arenas, Laura; (...); Berenguer, Marina

Article. 10.1111/liv.16085. 2024

First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma

Gonzalez, J. A.; (...); Lopez Pousa, A.

Meeting Abstract. 10.1016/j.annonc.2023.09.1161. 2023

First-in-human CEB-01: Novel loco-regional SN-38 release membrane to prevent local recurrence in retroperitoneal sarcomas

Gonzalez-Lopez, Jose Antonio; (...); Pousa, Antonio Lopez

Meeting Abstract. https://doi.org/10.1016/j.annonc.2023.09.1161. 2024

First-line chemotherapy with or without targeted therapies in metastatic colorectal cancer: The GEMCAD 14-01 prospective cohort

Oliveres, H.; (...); Maurel, J.

Meeting Abstract. 10.1016/j.annonc.2023.09.1796. 2023

Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023

Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study

Puchades, Lorena; (...); Berenguer, Marina

Article. 10.1097/TXD.0000000000001599. 2024

Free automatic software for quality assurance of computed tomography calibration, edges and radiomics metrics reproducibility.

Saborido-Moral, Juan D.; (...); Carles, Montserrat

Article. 10.1016/j.ejmp.2023.103153. 2023

Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.

Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria

Article. 10.1016/j.aohep.2022.100724. 2022

Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022

Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients.

Perez-Rubio, Alvaro; (...); Jover, Ramiro

Article. 10.3390/nu15143187. 2023

Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022

Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling

Noon, Luke; (...); Lloyd, Alison

Meeting Abstract. 2023

HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity

Andrade, Rita; (...); Cardoso, Joana

Article. 10.3390/cancers17030500. 2025

Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.

Rodríguez-Lescure Á; (...); de la Haba-Rodriguez J

Article. 10.1007/s12094-024-03411-w. 2024

IDENTIFICATION OF CANDIDATES FOR MASLD TREATMENT WITH INDETERMINATE VIBRATION- CONTROLLED TRANSIENT ELASTOGRAPHY

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2024

Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1016/j.cgh.2024.10.014. 2024

ImmunoSarc2: A Spanish Sarcoma Group (GEIS) phase Ib trial of doxorubicin and dacarbazine plus nivolumab in first line treatment of advanced leiomyosarcoma

Martin Broto, Javier; (...); Hindi, Nadia

Meeting Abstract. 2023

Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions.

Lopez-Campos, Fernando; (...); Couñago F

Article. 10.3390/biomedicines10030537. 2022

Impact of the European Society of Gastrointestinal Endoscopy 2020 guidelines on the number of scheduled post-polypectomy surveillance colonoscopies

Bustamante-Balen, Marco; (...); Pons-Beltran, Vicente

Article. 10.1055/a-1905-0155. 2022

Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma

Cabeza-Segura, Manuel; (...); Fleitas, Tania

Article. 10.1038/s41416-022-02005-z. 2022

Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024

Long-term outcomes after breast cancer liver metastasis surgery: A European, retrospective, snapshot study (LIBREAST STUDY).

Cantalejo-Diaz, Miguel; (...); Serradilla-Martin, Mario

Article. 10.1016/j.suronc.2024.102129. 2024

Machine Learning-Based Analysis in the Management of Iatrogenic Bile Duct Injury During Cholecystectomy: a Nationwide Multicenter Study

Lopez-Lopez, Victor; (...); Robles-Campos, Ricardo

Article. 10.1007/s11605-022-05398-7. 2022

Magnetic resonance imaging-based biomarker accurately identifies patients with nonalcoholic steatohepatitis and significant liver fibrosis: a multicentre, international, validation study

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2022

Maintenance of angiogenesis inhibition with aflibercept after progression to bevacizumab in metastatic colorectal cancer: real life study in the Valencian community.

Raga, Mireia Gil; (...); Hernandez, Isabel Busquier

Article. 10.1007/s12094-022-03047-8. 2023

Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group.

Gonzalez-del-Alba, Aranzazu; (...); Climent, Miguel Angel

Article. 10.3390/cancers14051130. 2022

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022

Multi-Institutional Analysis of Metastasis Directed Therapy with or without Androgen Deprivation Therapy in Oligometastatic Castration Sensitive Prostate Cancer.

Sutera, P.; (...); Sweeney, C.

Article. 10.1016/j.ijrobp.2023.06.1620. 2023

Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.

Deek MP; (...); Sweeney C

Article. 10.1016/j.euo.2024.03.010. 2024

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022

Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).

Gronchi, Alessandro; (...); Casali, Paolo Giovanni

Article. 10.1200/JCO.23.00908. 2024

Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Results of the expanded cohort of myxoid liposarcoma of the randomized clinical trial from the Italian Sarcoma Group (ISG), the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG).

Gronchi, Alessandro; (...); Casali, Paolo Giovanni

Meeting Abstract. 2022

Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022

ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023

Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.

Achard V; (...); Zilli T

Article. 10.1016/j.radonc.2022.04.020. 2022

Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023

OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024

Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022

PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute toxicity of a randomized phase II trial

Ost, P.; (...); Zilli, T.

Meeting Abstract. 2022

PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity

Zilli, T.; (...); Ost, P.

Meeting Abstract. 2022

PEACE V-Salvage Treatment of oligorecurrent nodal prostate cancer metastases (STORM): 24-months toxicity results of a randomized phase II trial

Zilli, T.; (...); Ost, P.

Meeting Abstract. 2024

PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial.

Ost, Piet; (...); Zilli, Thomas

Article. 10.1016/j.euo.2023.09.007. 2023

Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol

Salazar, Juliana; (...); Sebio, Ana

Article. 10.3390/pharmaceutics16121585. 2024

Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022

Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS).

Martin-Broto J; (...); Hindi N

Article. 10.1200/JCO.24.00358. 2024

Phase II trial of palbociclib in advanced sarcoma overexpressing CDK4 gene excluding dedifferentiated liposarcoma (DD LPS): A study from the Spanish Group for Research on Sarcoma (GEIS).

Broto, Javier Martin; (...); Hindi, Nadia

Meeting Abstract. 2022

Polyribonucleotide phosphorylase is overexpressed in hepatocellular cancer, promoting epithelial phenotype maintenance and tumor progression

Revert-Ros, Francisco; (...); Hernandez-Andreu, Jose Miguel

Article. 10.1016/j.prp.2024.155713. 2024

Post-transplant recurrence patterns after liver transplantation for hepatocellular carcinoma: an international multicenter study

Claasen, M. P. A. W.; (...); Polak, W. G.

Meeting Abstract. 2023

Precision medicine in metastatic colorectal cancer: targeting KRAS G12C mutation

Aparicio, Jorge

Article. 10.21037/tgh-24-28. 2024

Predicting major bleeding events in anticoagulated cancer patients with venous thromboembolism using real-world data and machine learning.

Martin, Andres J. Munoz; (...); Hernandez-Presa, Miguel Angel

Meeting Abstract. 2022

Predicting recurrence of venous thromboembolism in anticoagulated cancer patients using real-world data and machine learning.

Martin, Andres J. Munoz; (...); Hernandez-Presa, Miguel Angel

Meeting Abstract. 2022

Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processing.

Munoz Martin, Andres J; (...); Hernandez-Presa, Miguel Angel

Article. 10.1007/s12094-024-03586-2. 2024

Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.

Falkenhain-Lopez, D; (...); Ortiz-Romero, P L

Article. 10.1016/j.ad.2022.11.010. 2023

Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.

Boormans, Joost L; (...); Laguna, M Pilar

Article. 10.1016/j.euo.2023.10.014. 2023

Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict

Silva, Silvia Gomes; (...); Cardoso, Joana

Meeting Abstract. 2024

Progress and challenges of mid-infrared spectroscopy for liver characterization focusing on steatosis, fibrosis and cancer

Ten-Domenech, Isabel; (...); Quintas, Guillermo

Review. 10.1080/05704928.2023.2215858. 2024

Psychiatric symptoms in a Spanish sample with hereditary cancer risk.

Costa-Requena G; (...); Segura-Huerta Á

Article. 10.1007/s12687-022-00580-5. 2022

Quantitative evaluation of a non-CT based attenuation correction method for a new dedicated brain PET

Gandia-Ferrero, M.; (...); Marti-Bonmati, L.

Meeting Abstract. 2022

Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat

Quintas, Guillermo; (...); Jover, Ramiro

Article. 10.3390/ijms23169298. 2022

Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases.

Olivan-Sasot, P; (...); Olivas-Arroyo, C

Article. 10.1016/j.rxeng.2021.03.001. 2023

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01)

Aparicio, Jorge; (...); Maurel, Joan

Article. 10.1007/s12094-022-02868-x. 2022

Real-world dosing patterns of regorafenib for patients with metastatic colorectal cancer in Spain: the RE-SEARCH study.

López Muñoz AM; (...); Martín Gómez T

Article. 10.1007/s12094-024-03630-1. 2024

Real-world effectiveness and safety of second- or third-line pegylated liposomal irinotecan plus 5-fluorouracil and folinic acid in pancreatic ductal adenocarcinoma in Spain

Alvarez-Gallego, Rafael; (...); Cubillo, Antonio

Article. 10.1177/17588359241309828. 2025

Real-world evidence analysis of early-stage prostate cancer using natural language processing

Juarez, Alvaro; (...); Alcaraz, Antonio

Meeting Abstract. 2023

Real-world study on characteristics of advanced melanoma patients with sustained complete response (CR) after elective 1st line anti-programmed death-1 (anti-PD1) monotherapy discontinuation.

Ochenduszko, Sebastian; (...); Maestu, Inmaculada

Meeting Abstract. 2022

Recipient-Donor Sex Constellation in Liver Transplantation for Hepatocellular Carcinoma-An ELTR Study

Magyar, Christian Tibor Josef; (...); Banz, Vanessa

Article. 10.1111/liv.16178. 2025

Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments

Giuliani, Tommaso; (...); Lopez-Andujar, Rafael

Article. 10.1159/000539460. 2024

Redefining radiologic responses (RR) in solid tumors: Shall we brace ourselves for a post-RECIST era? Results from a randomized clinical trial (RCT) on neoadjuvant chemotherapy in high-risk soft-tissue sarcomas (HR-STS) of the trunk or extremities

Vanzulli, Andrea; (...); Gronchi, Alessandro

Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.11553. 2024

Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial.

Vanzulli, A; (...); Gronchi, A

Article. 10.1016/j.esmoop.2025.104299. 2025

Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity

Germain, J.; (...); Conde, A.

Meeting Abstract. 2023

Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.

Gandia-Ferrero, Maria Teresa; (...); Marti-Bonmati, Luis

Article. 10.1016/j.bbr.2023.114844. 2024

Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID).

Rojas-Holguin, Adela; (...); Blanco-Fernandez, Gerardo

Article. 10.1016/j.suronc.2024.102039. 2024

Retrospective real-world data study using natural language processing to describe treatment sequence and clinicopathological patterns in patients with metastatic colorectal cancer in five Spanish institutions

Vera Garcia, R.; (...); Mondejar Solis, R.

Meeting Abstract. 10.1016/j.annonc.2023.04.343. 2023

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Gounder, Mrinal M.; (...); Attia, Steven

Article. 10.1200/JCO.21.01829. 2022

Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study.

Valladares-Ayerbes M; (...); Lloansí Vila A

Article. 10.1007/s12094-024-03487-4. 2024

SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022

Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy.

Pasquali, Sandro; (...); Gronchi, Alessandro

Article. 10.1016/j.ebiom.2024.105220. 2024

The Development of a Non-Invasive Screening Method Based on Serum microRNAs to Quantify the Percentage of Liver Steatosis

Soluyanova, Polina; (...); Jover, Ramiro

Article. 10.3390/biom14111423. 2024

The Impact of Sleeve Gastrectomy on Gastroesophageal Reflux Disease in Patients with Morbid Obesity.

Sancho Moya C; (...); Montalvá Orón E

Article. 10.1007/s11695-021-05808-w. 2022

The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024

Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024

Two stage hepatectomy (TSH) versus ALPPS for initially unresectable colorectal liver metastases: A systematic review and meta-analysis.

Díaz Vico T; (...); Granero Trancon, Jose Electo

Article. 10.1016/j.ejso.2022.11.010. 2022

Update on the management of elderly patients with colorectal cancer.

Soler-Gonzalez, Gemma; (...); Girones-Sarrio, Regina

Article. 10.1007/s12094-023-03243-0. 2023

Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS).

Alvarez Alvarez, Rosa; (...); Asencio, Jose Manuel

Article. 10.3390/cancers15123194. 2023

Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.

Puchades, L.; (...); Berenguer, M.

Meeting Abstract. 2023

VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023

Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry

Tejedor, Marta; (...); Berenguer, Marina

Meeting Abstract. 2024

Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.

Tejedor, Marta; (...); Berenguer, Marina

Article. 10.3389/ti.2024.12732. 2024

Y-90 PET/MR imaging optimization with a Bayesian penalized likelihood reconstruction algorithm.

Calatayud-Jordan, Jose; (...); Torres-Espallardo, Irene

Article. 10.1007/s13246-024-01452-7. 2024